Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares stood at 0.7 million during the last session, with the company’s beta value hitting 0.47. At the close of
During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 0.77 million, with the beta value of the company hitting 0.47. At the end
In the last trading session, 1.45 million Viridian Therapeutics Inc (NASDAQ:VRDN) shares changed hands as the company’s beta touched 0.43. With the company’s per share
As the biotechnology business prepares to take part in a significant event, shares of Viridian Therapeutics Inc. (Nasdaq: VRDN) were up 13.64% at $26.00 at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne